305 related articles for article (PubMed ID: 30648915)
1. Acute Vaso-Occlusive Pain is Temporally Associated with the Onset of Menstruation in Women with Sickle Cell Disease.
Sharma D; Day ME; Stimpson SJ; Rodeghier M; Ghafuri D; Callaghan M; Zaidi AU; Hannan B; Kassim A; Zempsky W; Wellons M; James A; Bruehl S; DeBaun MR
J Womens Health (Larchmt); 2019 Feb; 28(2):162-169. PubMed ID: 30648915
[TBL] [Abstract][Full Text] [Related]
2. Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises.
Segbefia C; Campbell J; Tartaglione I; Asare EV; Andemariam B; Zempsky W; Colombatti R; Boatemaa GD; Boruchov D; Rao S; Piccone CM; Smith A; Haile H; Kim E; Wilson S; Farooq F; Urbonya R; Rivers A; Manwani D; Gai J; Sey F; Inusa B; Antwi-Boasiako C; Strunk C; Campbell AD
J Womens Health (Larchmt); 2023 Dec; 32(12):1284-1291. PubMed ID: 38011013
[No Abstract] [Full Text] [Related]
3. Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: A Focus Group Analysis.
Day M; Bonnet K; Schlundt DG; DeBaun M; Sharma D
Womens Health Rep (New Rochelle); 2020; 1(1):36-46. PubMed ID: 33786471
[No Abstract] [Full Text] [Related]
4. Common gynecological challenges in adolescents with sickle cell disease.
Stimpson SJ; Rebele EC; DeBaun MR
Expert Rev Hematol; 2016; 9(2):187-96. PubMed ID: 26613137
[TBL] [Abstract][Full Text] [Related]
5. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
7. Contraceptive Methods and the Impact of Menstruation on Daily Functioning in Women with Sickle Cell Disease.
Day ME; Stimpson SJ; Rodeghier M; Ghafuri D; Callaghan M; Zaidi AU; Hannan B; Kassim A; James AH; DeBaun MR; Sharma D
South Med J; 2019 Mar; 112(3):174-179. PubMed ID: 30830232
[TBL] [Abstract][Full Text] [Related]
8. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
Tripathi A; Jerrell JM; Stallworth JR
Ann Hematol; 2011 Feb; 90(2):145-50. PubMed ID: 20714723
[TBL] [Abstract][Full Text] [Related]
10. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
[TBL] [Abstract][Full Text] [Related]
11. Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.
Masese RV; Bulgin D; Knisely MR; Preiss L; Stevenson E; Hankins JS; Treadwell MJ; King AA; Gordeuk VR; Kanter J; Gibson R; Glassberg JA; Tanabe P; Shah N;
PLoS One; 2021; 16(10):e0258638. PubMed ID: 34714833
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
Wilson TT; Chou SC; Becker S; Schuur JD; Beaudoin F
Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567
[TBL] [Abstract][Full Text] [Related]
13. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
14. Early Initiation of Sub-Anesthetic Ketamine Infusion in Adults with Vaso-Occlusive Crises Is Associated with Greater Reduction in Sickle Cell Pain Intensity: A Single Center's Experience.
Kenney MO; Becerra B; Mallikarjunan A; Shah N; Smith WR
Pain Med; 2022 Dec; 23(12):2042-2049. PubMed ID: 35708641
[TBL] [Abstract][Full Text] [Related]
15. Increased Patient Activation Is Associated with Fewer Emergency Room Visits and Hospitalizations for Pain in Adults with Sickle Cell Disease.
Cronin RM; Dorner TL; Utrankar A; Allen W; Rodeghier M; Kassim AA; Jackson GP; DeBaun MR
Pain Med; 2019 Aug; 20(8):1464-1471. PubMed ID: 30329108
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell Disease.
Lyon M; Sturgis L; Lottenberg R; Gibson ME; Eck J; Kutlar A; Gibson RW
Ann Emerg Med; 2020 Sep; 76(3S):S12-S20. PubMed ID: 32928457
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
18. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin genotype predicts severe acute vaso-occlusive pain episodes in children with sickle cell anemia.
Willen SM; McNeil JB; Rodeghier M; Kerchberger VE; Shaver CM; Bastarache JA; Steinberg MH; DeBaun MR; Ware LB
Am J Hematol; 2020 Apr; 95(4):E92-E95. PubMed ID: 31919880
[No Abstract] [Full Text] [Related]
20. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
